Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
21
datasets available to search
ShareScore release 0.9.0
Dataset results
21 results for “proteinase inhibitors”
Figure 3 in Partially purified Glycine max proteinase inhibitors: potential bioactive compounds against tobacco cutworm, Spodoptera litura (Fabricius, 1775) (Lepidoptera: Noctuidae)
Figure 3. Food assimilation (in mg) with respect to control when second-instar larvae of S. litura were given different concentrations of soybean PIs. Columns and bars represent the mean ± SE. Different letters above the columns representing each concentration indicate significant differences with Tukey's test at P ≤ 0.05.
Figure 2 in Partially purified Glycine max proteinase inhibitors: potential bioactive compounds against tobacco cutworm, Spodoptera litura (Fabricius, 1775) (Lepidoptera: Noctuidae)
Figure 2. Percentage survival of adults when second-instar larvae of S. litura were given different concentrations of soybean PIs. Columns and bars represent the mean ± SE. Different letters above the columns representing each concentration indicate significant differences with Tukey's test at P ≤ 0.05.
Figure 1 in Partially purified Glycine max proteinase inhibitors: potential bioactive compounds against tobacco cutworm, Spodoptera litura (Fabricius, 1775) (Lepidoptera: Noctuidae)
Figure 1. (A) Normal S. litura adult, (B–D) abnormality in adults observed at 100 µg/mL concentration of soybean PIs.
Figure 4 in Partially purified Glycine max proteinase inhibitors: potential bioactive compounds against tobacco cutworm, Spodoptera litura (Fabricius, 1775) (Lepidoptera: Noctuidae)
Figure 4. Trypsin activity in larvae of S. litura at different time intervals under the influence of partially purified soybean PIs.
Safety and Pharmacokinetics of Alpha-1 MP (Alpha1-proteinase Inhibitor (Human), Modified Process) in Participants With Alpha1-Antitrypsin Deficiency
ClinicalTrials.gov study NCT02870309. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE)
ClinicalTrials.gov study NCT02870348. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
ClinicalTrials.gov study NCT02093221. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency
ClinicalTrials.gov study NCT00261833. IPD Sharing: Not stated. Countries: 13. Publications: 2.
Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)
ClinicalTrials.gov study NCT00396006. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.
ClinicalTrials.gov study NCT00670007. IPD Sharing: Not stated. Countries: 11. Publications: 3.
Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)
ClinicalTrials.gov study NCT01983241. IPD Sharing: Not stated. Countries: 17. Publications: 1.
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
ClinicalTrials.gov study NCT01213043. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency
ClinicalTrials.gov study NCT00460096. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)
ClinicalTrials.gov study NCT04547140. IPD Sharing: NO. Countries: 5. Publications: 0.
Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis
ClinicalTrials.gov study NCT01684410. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Safety and PK of Liquid Alpha₁-Proteinase Inhibitor (Human) in Treating Alpha₁-Antitrypsin Deficiency
ClinicalTrials.gov study NCT02282527. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Aralast alpha1-proteinase Inhibitor Surveillance Study
ClinicalTrials.gov study NCT00313144. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of RYMPHYSIA for Alpha1-Proteinase Inhibitor (A1PI) Therapy in Adults With A1PI Deficiency and Chronic Obstructive Pulmonary Disease (COPD)-Emphysema
ClinicalTrials.gov study NCT05466747. IPD Sharing: YES. Countries: 0. Publications: 0.
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency
ClinicalTrials.gov study NCT04722887. IPD Sharing: NO. Countries: 1. Publications: 0.
Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
ClinicalTrials.gov study NCT02796937. IPD Sharing: NO. Countries: 11. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.